EVH · Evolent Health, Inc. · Webcasts, Transcripts & Audio
$3.90
+0.47 (+13.70%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$441.11M
Shares
113.11M
Volume · Nov 20
4.42M
Avg daily vol (3M)
2.16M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Evolent Health, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Evolent Health, Inc. (EVH), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-05
Evolent Health, Inc. (EVH) Q3 2026 Earnings Call Transcript
Confident tone
Oncology growth and clinical innovation
Performance suite launches
AI-enabled prior authorization
Revenue
$725.37M
▲ 51.3% YoY Diluted EPS
$-0.21
Gross margin
12.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-06
Evolent Health, Inc. (EVH) Q2 2026 Earnings Call Transcript
Confident tone
Performance Suite launches and growth
2027 Medicaid and exchange headwinds
Medical Expense Ratio and reserving
Revenue
$652.52M
▲ 46.9% YoY Diluted EPS
$-0.25
Gross margin
12.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript
Positive tone
Performance Suite and new client launches
Oncology and medical cost trend
Financial guidance and outlook
Revenue
$496.25M
▲ 2.6% YoY Diluted EPS
$-0.24
Gross margin
16.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Evolent Health, Inc. (EVH) Q4 2025 Earnings Call Transcript
Positive tone
2026 revenue and EBITDA guidance
Performance Suite contract migration
New partnerships and customer wins
Revenue
$468.72M
▼ 27.5% YoY Diluted EPS
$-3.84
Gross margin
20.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Evolent Health, Inc. (EVH) Q3 2025 Earnings Call Transcript
Confident tone
Oncology market opportunity and pipeline
Performance Suite and enhanced protections
Margin expansion and adjusted EBITDA
Revenue
$479.53M
▼ 22.8% YoY Diluted EPS
$-0.24
Gross margin
20.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Evolent Health, Inc. (EVH) Q2 2025 Earnings Call Transcript
Positive tone
Oncology trend and Performance Suite
New partner wins and pipeline
2026 outlook
Revenue
$444.33M
▼ 31.3% YoY Diluted EPS
$-0.44
Gross margin
22.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Evolent Health, Inc. (EVH) Q1 2025 Earnings Call Transcript
Revenue
$483.65M
▼ 24.4% YoY Diluted EPS
$-0.63
Gross margin
21.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
Evolent Health, Inc. (EVH) Q4 2024 Earnings Call Transcript
Positive tone
Oncology cost trend and Performance Suite profitability
Organic growth and new contracts
2025 financial outlook and guidance
Revenue
$646.54M
▲ 16.3% YoY Diluted EPS
$-0.27
Gross margin
11.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Evolent Health, Inc. (EVH) Q3 2024 Earnings Call Transcript
Cautious tone
Reimbursement rate renegotiation
Specialty performance suite underwriting losses
2024 guidance reset / lowered EBITDA outlook
Revenue
$621.40M
▲ 21.6% YoY Diluted EPS
$-0.27
Gross margin
13.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript
Positive tone
2024 Adjusted EBITDA Guidance and $300M Exit Run Rate Target
New Revenue Agreements / Bookings
Rate Increases from Performance Suite Partners
Revenue
$647.14M
▲ 37.9% YoY Diluted EPS
$-0.06
Gross margin
16.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Evolent Health, Inc. (EVH) Q1 2024 Earnings Call Transcript
Positive tone
Revenue growth and guidance raise
Profitability and EBITDA expansion
Utilization and risk business pressures
Revenue
$639.65M
▲ 49.6% YoY Diluted EPS
$-0.22
Gross margin
16.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-22
Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript
Confident tone
Financial Results and 2024 Outlook
Specialty Care / Performance Suite Expansion
Oncology and Technology and Services Suite
Revenue
$556.05M
▲ 45.4% YoY Diluted EPS
$-0.36
Gross margin
18.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Evolent Health, Inc. (EVH) Q3 2023 Earnings Call Transcript
Revenue
$511.01M
▲ 44.9% YoY Diluted EPS
$-0.30
▼ 1600% YoY Gross margin
24.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Evolent Health, Inc. (EVH) Q2 2023 Earnings Call Transcript
Revenue
$469.14M
▲ 46.6% YoY Diluted EPS
$-0.37
Gross margin
25.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Evolent Health, Inc. (EVH) Q1 2023 Earnings Call Transcript
Revenue
$427.69M
▲ 44% YoY Diluted EPS
$-0.24
Gross margin
27.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Evolent Health, Inc. (EVH) Q4 2022 Earnings Call Transcript
Revenue
$382.43M
▲ 54% YoY Diluted EPS
$-0.11
Gross margin
21.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Evolent Health, Inc. (EVH) Q3 2022 Earnings Call Transcript
Revenue
$352.58M
▲ 58.5% YoY Diluted EPS
$0.02
Gross margin
24.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Evolent Health, Inc. (EVH) Q2 2022 Earnings Call Transcript
Revenue
$319.94M
▲ 44.1% YoY Diluted EPS
$-0.05
Gross margin
22.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Evolent Health, Inc. (EVH) Q1 2022 Earnings Call Transcript
Revenue
$297.06M
▲ 38.1% YoY Diluted EPS
$-0.06
Gross margin
26.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-11
Evolent Health, Inc. (EVH) Q4 2021 Earnings Call Transcript
Revenue
$248.36M
▲ 0.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Evolent Health, Inc. (EVH) Q3 2021 Earnings Call Transcript
Revenue
$222.47M
▼ 7.1% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Evolent Health, Inc. (EVH) Q2 2021 Earnings Call Transcript
Revenue
$222.06M
▲ 2.2% YoY Diluted EPS
$-0.11
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Evolent Health, Inc. (EVH) Q1 2021 Earnings Call Transcript
Revenue
$215.07M
▼ 2.8% YoY Diluted EPS
$-0.12
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Evolent Health, Inc. (EVH) Q4 2020 Earnings Call Transcript
Revenue
$246.54M
▲ 4.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Evolent Health, Inc. (EVH) Q3 2020 Earnings Call Transcript
Revenue
$239.57M
▲ 8.8% YoY Diluted EPS
$-0.44
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-17
Evolent Health, Inc. (EVH) Q2 2020 Earnings Call Transcript
Revenue
$217.30M
▲ 13.2% YoY Diluted EPS
$-2.38
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Evolent Health, Inc. (EVH) Q1 2020 Earnings Call Transcript
Revenue
$221.23M
▲ 11.9% YoY Diluted EPS
$-0.93
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Evolent Health, Inc. (EVH) Q4 2019 Earnings Call
Revenue
$236.53M
▲ 22.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 webcasts
Key facts
CIK
1628908
CUSIP
30050B101
13F (30d)
212 filings
189 filers
Visit website
Investor relations